sodium 2,2-dimethylbutyrate

Small moleculeexperimental

Clinical trial activity

8 trials · 6 clinical orgs · 0 marketing orgs

Phase 1
4
Phase 2
6
Phase 3
0
Phase 4
0

Earliest trial started Jan 1, 2008 (NCT00614016)

Timeline

2000s

  1. Jan 1, 2008

    Earliest Phase 1 Sponsor(trial)

2010s

  1. Jan 1, 2011

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Loading structure…

SMILES

CCC(C)(C)C(=O)[O-].[Na+]
Mol. weight
138.14 g/mol
Lipinski Ro5
Pass
Rule of 3
Yes
Chirality
Achiral Molecule
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • 2,2-dimethylbutanoic acid
  • 2,2-dimethylbutyric acid
  • 2,2-dmb
  • hqk-1001
  • hqk-1001
  • hqk-1001
  • nsc741804
  • nsc 741804
  • nsc-741804
  • sodium 2,2 dimethylbutyrate
  • sodium 2,2 dimethylbutyrate
  • sodium 2,2-dimethylbutyrate
  • st20
  • st20
  • st-20 compound

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT01601340Phase 2Jul 1, 2012HemaQuest Pharmaceuticals
NCT01642758Phase 2May 1, 2012Boston University, HemaQuest Pharmaceuticals, Rafik Hariri University
NCT01609595Phase 2Mar 1, 2012Boston University, Mahidol University
NCT01322269Phase 2Apr 1, 2011HemaQuest Pharmaceuticals
NCT00842088Phase 1/Phase 2 (Phase 2)Mar 1, 2009HemaQuest Pharmaceuticals
NCT00790127Phase 1/Phase 2 (Phase 2)Mar 1, 2009HemaQuest Pharmaceuticals, Siriraj Hospital
NCT00717262Phase 1May 1, 2008Charles River, HemaQuest Pharmaceuticals
NCT00614016Phase 1Jan 1, 2008Charles River, HemaQuest Pharmaceuticals
Showing 8 of 8 trials
Page 1 / 1

Organizations

Research & Development (6)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
HemaQuest PharmaceuticalsFor profit7622008
Boston UniversityAcademic/Hospital2212012
Charles RiverFor profit2012008
Mahidol UniversityAcademic/Hospital1012012
Rafik Hariri UniversityAcademic/Hospital1012012
Siriraj HospitalAcademic/Hospital1012009
6 organizations
Page 1 / 1